Search Result "(ODNs)"
Neuroprotection with the Endozepine Octadecaneuropeptide, ODN
Journal: Current Pharmaceutical Design
Volume: 24 Issue: 33 Year: 2018 Page: 3918-3925
Author(s): Olfa Masmoudi-Kouki,Yosra Hamdi,Ikram Ghouili,Seyma Bahdoudi,Hadhémi Kaddour,Jérôme Leprince,Hélène Castel,Hubert Vaudry,Mohamed Amri,David Vaudry,Marie-Christine Tonon
Enhancement of Immunoprotective Effect of CpG-ODN by Formulation with Polyphosphazenes Against E. coli Septicemia in Neonatal Chickens
Journal: Current Drug Delivery
Volume: 6 Issue: 1 Year: 2009 Page: 76-82
Author(s): Azita Taghavi, Brenda Allan, George Mutwiri, Marianna Foldvari, Andrew Van Kessel, Philip Willson, Lorne Babiuk, Andrew Potter, Susantha Gomis
Antisense Oligodeoxyribonucleotides (AS-ODNs) for Cancer Gene Therapy: A Clinical Perspective
Ebook: Molecular Oncology: Principles and Recent Advances
Volume: 1 Year: 2012
Author(s): Maria Luisa Benitez-Hess,Luis Marat Alvarez-Salas
Doi: 10.2174/978160805016111201010198
Transcription Factors as Molecular Targets: Molecular Mechanisms of Decoy ODN and their Design
Journal: Current Drug Targets
Volume: 4 Issue: 8 Year: 2003 Page: 603-608
Author(s): Naruya Tomita, Toshio Ogihara, Ryuichi Morishita
An Oligodeoxynucleotide with CCT Repeats Restrains CpG ODN-Induced TLR9 Trafficking
Journal: Current Pharmaceutical Biotechnology
Volume: 15 Issue: 9 Year: 2014 Page: 780-789
Author(s): Xiaoling Zhang,Wei Sun,Xiuli Wu,Hua Wang,Youyou Yan,Sheng Guo,Dandan Song,Hainan Li,Shuang Gao,Luowei Wang,Yongli Yu,Liying Wang
Inhibitory Effects of Cathepsin K Inhibitor (ODN-MK-0822) on the Paracrine Pro-Osteoclast Factors of Breast Cancer Cells
Journal: Current Molecular Pharmacology
Volume: 14 Issue: 6 Year: 2021 Page: 1134-1145
Author(s): Yaongamphi Vashum,Amuthavalli Kottaiswamy,Giridharan Bupesh,Riya P. Singh,Parkavi Kalaiselvan,K. Thiagarajan,Shila Samuel
Synthetic Oligodeoxynucleotides Containing Deoxycytidyl-Deoxyguanosine Dinucleotides (CpG ODNs) and Modified Analogs as Novel Anticancer Therapeutics
Journal: Current Pharmaceutical Design
Volume: 11 Issue: 2 Year: 2005 Page: 2889-2907
Author(s): H. Wang, E. Rayburn, R. Zhang
The TLR9 Antagonist iCpG-ODN at Different Dosages Inhibits Cerebral Ischemia/Reperfusion Injury in Mice
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 16 Issue: 5 Year: 2017 Page: 624-633
Author(s): Ying Zhou,Jingrui Pan,Qingxia Peng,Zhaofei Dong,Lingna Deng,Yidong Wang
Chitosan Nanoparticles: A Therapeutic Carrier for Delivery of DNA, siRNA and CpG-ODNs
Journal: Nanoscience & Nanotechnology-Asia
Volume: 6 Issue: 2 Year: 2016 Page: 92-104
Author(s): Manpreet Kaur,Dimple Sethi,Aruna Bhatia
Therapeutic Effect of Ribbon-Type Nuclear Factor-κB Decoy Oligonucleotides in a Rat Model of Inflammatory Bowel Disease
Journal: Current Gene Therapy
Volume: 12 Issue: 6 Year: 2012 Page: 484-492
Author(s): Kazunari Ozaki,Hirofumi Makino,Motokuni Aoki,Takashi Miyake,Natsuki Yasumasa,Mariana Kiomy Osako,Hironori Nakagami,Hiromi Rakugi,Ryuichi Morishita